- Works count
- 56
- Citation count
- 5,508
- H-index
- 24
- i10-index
- 32
Research interests
Publications
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
Blood · 2012 · 10.1182/blood-2011-09-377713
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Blood · 2012 · 10.1182/blood-2012-07-441030
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.32.7270
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
Leukemia · 2007 · 10.1038/sj.leu.2404586
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
Blood · 2005 · 10.1182/blood-2005-07-2708
Current projects
No projects listed.